GE HealthCare reports third quarter 2026 financial results
Delivers top- and bottom-line growth ahead of Company expectations and raises full-year 2026 guidance Revenue growth of 7.2%, and Organic revenue growth* of 6.2% Organic orders growth of 4.0%, book-to-bill of 1.03 times and backlog of $23.7 billion Net income margin of 11.1% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.6%; diluted EPS of $1.36 grew 39.1% and Adjusted EPS* of $1.34 grew 25.1% Cash flow from operating activities of $907 million and Free cash flow* of $793 million GE HealthCare (NASDAQ:GEHC) today reported financial results for the third quarter ended September 30, 2026. GE HealthCare President and CEO Peter Arduini said, "We delivered